The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1337
May 3, 2010
View Complete Issue         Table of Contents 2019 
Issue 1337
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
In Brief: Poor Metabolizers of Clopidogrel (Plavix)
May 3, 2010 (Issue: 1337)
The FDA has required the manufacturer of Plavix, an antiplatelet drug used in addition to aspirin to prevent cardiovascular events in high-risk patients,1 to add a boxed warning to the package insert about the risk of a poor response to the drug in...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1337
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.